Lyndhurst Centre, Toronto Rehabilitation Institute-UHN
Toronto, Ontario, M4G 3V9, Canada
NCT Number: NCT04262414
Up to 15 able-bodied individuals will participate in one testing session to evaluate the effectiveness of the A-FES system. Up to 20 individuals with SCI will participate in 12 sessions of A-FES therapy. At each session, participants will stand on a force plate (Accu Sway, AMTI, USA) with the A-FES system (Compex Motion II, Compex Motion, Switzerland) donned. The centre of pressure (COP) will be calculated in real time using the force plate data. The calculated COP will be presented to participants on a monitor and they will be instructed to shift their COP in the indicated directions as represented by a cursor (i.e. training with visual feedback). The intensity of electrical stimulation provided by the A-FES system will be regulated by the measured COP in a closed-loop manner. In this study we propose to develop and evaluate the clinically-feasible A-FES system for the training of standing balance.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Toronto, Ontario, M4G 3V9, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will be withdrawn from the study if FES irritates their skin.
The device used was a prototype closed-loop FES system to improve standing balance by activating the ankle plantar flexors and dorsiflexors (i.e. A-FES system). As a closed-loop system, the body's position and velocity are continually monitored, and the level of stimulation adjusted accordingly on a moment-to-moment basis. This differs from currently available FES units, which do not monitor body movement and therefore, provide a constant level of stimulation unless manually adjusted by the user/PT. The control strategy used in the A-FES system mimics the physiological control system in able-bodied people, meaning it has the potential to "re-educate" normal movement patterns.
Time frame: Change from Baseline Berg Balance Scale at 8 weeks
Assesses static and dynamic standing balance; score 0-56; higher score means a better outcome
Time frame: Change from Baseline Mini-Balance Evaluation Systems Test at 8 weeks
Assesses four balance control systems, including anticipatory balance, reactive postural control, sensory orientation and dynamic gait
Time frame: Change from Baseline Activities-specific Balance Confidence Scale at 8 weeks
A measure of balance self-efficacy; mean score of 0-100; higher score means a better outcome (i.e. high balance confidence)
Time frame: Through study completion, average of 8 weeks
Postural sway during quiet standing
Time frame: Through study completion, average of 8 weeks
Assessed by asking participants to lean as far as possible in the forward, backward and sideways directions while standing on a force plate (i.e. limits of stability test)
Time frame: up to 8 weeks post-intervention
The guide will include open-ended questions concerning the participant's experience with, and impressions of, A-FES therapy
University Health Network, Toronto
Other
Restoring Upright Mobility After Spinal Cord Injury Using Functional Electrical Stimulation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03922802
Central Nervous System Diseases, Hypoxia
Chicago, Illinois, United States
View Trial DetailsNCT05530798
Back Injuries, Bone Diseases
Charleston, South Carolina, United States
View Trial DetailsNCT05870189
Central Nervous System Diseases, Nervous System Diseases
Minneapolis, Minnesota, United States
View Trial DetailsNCT03459885
Central Nervous System Diseases, Nervous System Diseases
Helsinki, Uusimaa, Finland
View Trial Details